Search Results

This week's highlights: Kudos to our partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics meta-dynamics/FMO3 approach Industry News GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have

November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID offering of high-quality synthetic DNA using its silicon platform, today announced it has launched Revelar Biotherapeutics

April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare disorders, today announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund (the R-Bridge Financing)."

Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe

With a deep focus on structure-based drug design, Jens discusses how his lab bridges simulation and experiment—and Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. With a reputation for collaborative science, Jens is a strong advocate for bringing together chemists

Bridge theory to practical drug development decisions?